Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Gilead Sciences Inc (GILD)  
$67.31 0.44 (0.65%) as of 4:30 Tue 4/16


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 1,250,000,000
Market Cap: 84.14(B)
Last Volume: 4,974,963 Avg Vol: 8,762,846
52 Week Range: $68.12 - $87.29
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    S&P COMPOSITE 1500     NASDAQ BIOTECHNOLOGY
    NASDAQ COMPOSITE     NASDAQ-100
    S&P 500     NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  259
Guru Rank Value     : 4.6
Guru Occurances    : 2

 

            6 Months   1 Year   2 Year  
 
Company Profile   Gilead Sciences is a research-based biopharmaceutical company that discovers, develops and commercializes medicines. Co.'s primary areas of focus include viral diseases, inflammatory diseases and oncology. Co.'s products include: Biktarvy® for the treatment of HIV-1 infection in certain patients; Veklury® (remdesivir), for the treatment of Coronavirus Disease 2019 requiring hospitalization; Epclusa® for the treatment of chronic hepatitis C virus infection; Vemlidy® for the treatment of chronic hepatitis B virus infection in adults with compensated liver disease; Yescarta® (axicabtagene ciloleucel) for the treatment of adult patients with relapsed or refractory large B-cell lymphoma.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 12,230 25,472 38,458 80,792
Total Sell Value $890,904 $2,022,270 $3,052,046 $6,445,296
Total People Sold 1 3 3 4
Total Sell Transactions 3 5 9 14
End Date 2024-01-18 2023-10-17 2023-04-18 2022-04-18

   
Records found: 2491
  Page 1 of 100  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Parsey Merdad Chief Medical Officer   •       •      –    2024-04-01 4 AS $72.96 $145,920 D/D (2,000) 96,304 -7%     
   Telman Deborah H EVP, Corporate Affairs & GC   •       •      –    2024-03-10 4 D $75.12 $63,552 D/D (846) 13,757     -
   Telman Deborah H EVP, Corporate Affairs & GC   •       •      –    2024-03-10 4 OE $0.00 $0 D/D 2,555 14,603     -
   Patterson Sandra SVP, Controllership   •       •      –    2024-03-10 4 D $75.12 $59,345 D/D (790) 32,632     -
   Patterson Sandra SVP, Controllership   •       •      –    2024-03-10 4 OE $0.00 $0 D/D 2,682 33,422     -
   Dickinson Andrew D Chief Financial Officer   •       •      –    2024-03-10 4 D $75.12 $338,416 D/D (4,505) 134,983     -
   Dickinson Andrew D Chief Financial Officer   •       •      –    2024-03-10 4 OE $0.00 $0 D/D 9,732 139,488     -
   Parsey Merdad Chief Medical Officer   •       •      –    2024-03-10 4 D $75.12 $360,801 D/D (4,803) 98,304     -
   Parsey Merdad Chief Medical Officer   •       •      –    2024-03-10 4 OE $0.00 $0 D/D 10,401 103,107     -
   Mercier Johanna Chief Commercial Officer   •       •      –    2024-03-10 4 D $75.12 $342,472 D/D (4,559) 118,432     -
   Mercier Johanna Chief Commercial Officer   •       •      –    2024-03-10 4 OE $0.00 $0 D/D 9,844 122,991     -
   Oday Daniel Patrick Chairman & CEO   •       •      –    2024-03-10 4 D $75.12 $1,035,304 D/D (13,782) 484,847     -
   Oday Daniel Patrick Chairman & CEO   •       •      –    2024-03-10 4 OE $0.00 $0 D/D 29,940 498,629     -
   Parsey Merdad Chief Medical Officer   •       •      –    2024-02-29 4 AS $72.74 $598,624 D/D (8,230) 92,706 -6%     
   Parsey Merdad Chief Medical Officer   •       •      –    2024-02-28 4 AS $73.18 $146,360 D/D (2,000) 100,936 -6%     
   Love Ted W Director   •       •      –    2024-02-02 4 A $0.00 $0 D/D 512 512     -
   Dickinson Andrew D Chief Financial Officer   •       •      –    2024-01-31 4 D $78.26 $1,832,067 D/D (23,410) 129,436     -
   Dickinson Andrew D Chief Financial Officer   •       •      –    2024-01-31 4 A $0.00 $0 D/D 74,961 152,846     -
   Telman Deborah H EVP, Corporate Affairs & GC   •       •      –    2024-01-31 4 A $0.00 $0 D/D 4,646 11,728     -
   Mercier Johanna Chief Commercial Officer   •       •      –    2024-01-31 4 D $78.26 $1,761,554 D/D (22,509) 113,147     -
   Mercier Johanna Chief Commercial Officer   •       •      –    2024-01-31 4 A $0.00 $0 D/D 74,055 135,656     -
   Oday Daniel Patrick Chairman & CEO   •       •      –    2024-01-31 4 D $78.26 $6,208,757 D/D (79,335) 468,689     -
   Oday Daniel Patrick Chairman & CEO   •       •      –    2024-01-31 4 A $0.00 $0 D/D 230,747 548,024     -
   Parsey Merdad Chief Medical Officer   •       •      –    2024-01-31 4 D $78.26 $1,855,466 D/D (23,709) 102,616     -
   Parsey Merdad Chief Medical Officer   •       •      –    2024-01-31 4 A $0.00 $0 D/D 76,853 126,325     -
  2491 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 100
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us